Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antipsychotic-associated psoriatic rash - a case report.
Bujor CE, Vang T, Nielsen J, Schjerning O. Bujor CE, et al. Among authors: schjerning o. BMC Psychiatry. 2017 Jul 4;17(1):242. doi: 10.1186/s12888-017-1411-2. BMC Psychiatry. 2017. PMID: 28676105 Free PMC article.
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.
Larsen JR, Vedtofte L, Jakobsen MSL, Jespersen HR, Jakobsen MI, Svensson CK, Koyuncu K, Schjerning O, Oturai PS, Kjaer A, Nielsen J, Holst JJ, Ekstrøm CT, Correll CU, Vilsbøll T, Fink-Jensen A. Larsen JR, et al. Among authors: schjerning o. JAMA Psychiatry. 2017 Jul 1;74(7):719-728. doi: 10.1001/jamapsychiatry.2017.1220. JAMA Psychiatry. 2017. PMID: 28601891 Free PMC article. Clinical Trial.
Abuse Potential of Pregabalin: A Systematic Review.
Schjerning O, Rosenzweig M, Pottegård A, Damkier P, Nielsen J. Schjerning O, et al. CNS Drugs. 2016 Jan;30(1):9-25. doi: 10.1007/s40263-015-0303-6. CNS Drugs. 2016. PMID: 26767525 Review.
One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients.
Svensson CK, Larsen JR, Vedtofte L, Jakobsen MSL, Jespersen HR, Jakobsen MI, Koyuncu K, Schjerning O, Nielsen J, Ekstrøm CT, Correll CU, Vilsbøll T, Fink-Jensen A. Svensson CK, et al. Among authors: schjerning o. Acta Psychiatr Scand. 2019 Jan;139(1):26-36. doi: 10.1111/acps.12982. Epub 2018 Nov 28. Acta Psychiatr Scand. 2019. PMID: 30374965 Clinical Trial.
Cardiovascular safety of antipsychotics: a clinical overview.
Polcwiartek C, Kragholm K, Schjerning O, Graff C, Nielsen J. Polcwiartek C, et al. Among authors: schjerning o. Expert Opin Drug Saf. 2016 May;15(5):679-88. doi: 10.1517/14740338.2016.1161021. Epub 2016 Apr 1. Expert Opin Drug Saf. 2016. PMID: 26934282 Review.
High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine.
Larsen JR, Svensson CK, Vedtofte L, Jakobsen ML, Jespersen HS, Jakobsen MI, Koyuncu K, Schjerning O, Nielsen J, Ekstrøm CT, Holst JJ, Correll CU, Vilsbøll T, Fink-Jensen A. Larsen JR, et al. Among authors: schjerning o. CNS Spectr. 2019 Aug;24(4):441-452. doi: 10.1017/S1092852918001311. Epub 2018 Dec 31. CNS Spectr. 2019. PMID: 30596361
14 results